Therefore, the combined use of GLP-1 RAs with therapies targeting intrahepatic pathways, such as thyroid hormone receptor (THR-) agonists, fibroblast growth factor-21 (FGF21) analogues, and peroxisome proliferator-activated receptor (PPAR) agonists, presents a promising approach for MASH treatment
Obesity as a Neuro-Metabolic Disease Key mechanisms include: Neuroendocrine dysregulation of appetite and satiety Metabolic adaptation defending higher weight Environmental and behavioral feedback loops Strong relapse tendency requiring long-term care Lifestyle alone is rarely sufficient for durable control
3 Biotech 8:129
Since the body makes glutathion in response to stress, it should be found in the blood stream at healthy levels of 669 mm/L
Front Cell Neurosci 16 Mierziak J, Burgberger M, Wojtasik W (2021) 3-Hydroxybutyrate as a metabolite and a signal molecule regulating processes of living organisms
Zhou, B., Liu, J., Kang, R., Klionsky, D